Fasenra pen 30 MG/mlml
Ended Awarded Last action
- Contract number
- SPE2DR26FJXF6
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,195
Award facts
- Contract value 100% obligated
- $2,194.50 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $2,194.50 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for FASENRA PEN 30 MG/ML. This delivery order, issued on January 22, 2026, with an ultimate completion date of January 23, 2026, represents a routine pharmaceutical supply transaction under the agency's established contracting mechanisms. The award was made without a set-aside designation, reflecting DMS Pharmaceutical Group's competitive capability in unrestricted federal procurement. No subcontractors are identified for this delivery order.
This delivery order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract (IDC) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, awarded in November 2025 with a $499.999 billion ceiling and completion date of December 31, 2036. The PPV-G GEN V program, part of a broader $30.3 billion acquisition strategy, establishes multiple regional prime vendor contractors to supply a comprehensive range of pharmaceutical products, biologics, and medical consumables to support Department of Defense military healthcare facilities worldwide. DMS Pharmaceutical Group's established performance across numerous delivery orders demonstrates its critical role in the federal military medical supply chain.
Quick answers
Who was awarded contract SPE2DR26FJXF6?
SPE2DR26FJXF6 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 22, 2026.
How much is contract SPE2DR26FJXF6 worth?
The government has obligated $2,195 on SPE2DR26FJXF6.
Is contract SPE2DR26FJXF6 an order under another contract?
Yes. SPE2DR26FJXF6 is a delivery order under SPE2DR25D9307, an indefinite delivery contract.
Was contract SPE2DR26FJXF6 competed?
The extent of competition for SPE2DR26FJXF6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award